Results 201 to 210 of about 1,041,491 (350)

Anti-Biofilm Activity of Combinations of Cinnamic Acid and Its Derivatives with Cloxacillin Against Methicillin-Resistant <i>Staphylococcus epidermidis</i>. [PDF]

Curr Issues Mol Biol
Zawiła T, Swolana D, Zawiła M, Rzepka Z, Wojtyczka RD.   +4 more
europepmc   +1 more source

Insights into a long life without cancer: The case of the bowhead whale

Molecular Oncology, EarlyView.
Long‐lived, large‐bodied organisms have evolved powerful anticancer mechanisms that preserve cellular and tissue integrity across extended lifespans. A recent study by Firsanov et al. shows that greater genome stability is a key factor underlying the remarkable longevity and cancer resistance of one such species, the bowhead whale.
Inés Paniagua, Johanna A. Joyce
wiley   +1 more source

Exploring the differences in the invasion potential of <i>Sphagneticola trilobata</i> in three invasive habitats based on photosynthetic and photoprotective capacities. [PDF]

Photosynthetica
Yu ZC, Zhu H, Zheng YZ, Yu SY, Liu YF, Lin XL, Peng CL, Zheng XT.   +7 more
europepmc   +1 more source

Growth Regulating Substances in Extracts of Maple and Pear Flower Buds [PDF]

, 1958
Bailey, Lowell F., Tackett, Dewey L.
core   +2 more sources

Studies on application of growth substances to increase yield in sweet potatoes. II

, 1951
Hiroyuki Mori, S. Tsuchiya
openalex   +2 more sources

Growth in spending for substance abuse treatment services for the privately insured population [PDF]

, 2015
Cindy Parks Thomas, Tami L. Mark, Dominic Hodgkin, Katharine R. Levit   +3 more
openalex   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

A novel stationary phase approach for improved recombinant protein expression in Escherichia coli: beyond the exponential phase. [PDF]

Microb Cell Fact
Kang YH, Ryu YK, Lee J, Jo E, Gang Y, Kim T, Park GH, Oh C.   +7 more
europepmc   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Pathogenic effects of <i>Halomonas</i> on cyanobacteria and biocontrol potential of a deep-sea <i>Bacillus</i> strain. [PDF]

Appl Environ Microbiol
Li X, Yuan M, Sun C, Wu S.
europepmc   +1 more source